Analyst stock forecast
BioVie Forecast: $5.26 Analyst Target
BIVI has a $5.26 target, none rating and 2 analysts. As of 2026-08-18.
Direct answer
BioVie's average price target is $5.26.
The target implies +349.1% from the recorded current price, and the consensus rating is none.
The low target implies +327.4%, the high target implies +370.9%, and the range spans 43.6% of the current price.
Forecast evidence checked August 18, 2026.
Get free BioVie email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.17
- Average price target
- $5.26
- High price target
- $5.51
- Low price target
- $5.00
- Low target gap
- +327.4%
- Target upside
- +349.1%
- High target gap
- +370.9%
- Target range width
- 43.6%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- August 18, 2026
- Valid through
- August 25, 2026
Explore related company data
Read the frequently asked questions.
What is BioVie's average price target?
BioVie's verified average price target is $5.26. The target range is $5.00 to $5.51.
How far are BioVie's low and high targets from the recorded price?
The low target implies +327.4%, while the high target implies +370.9%.
How many analysts are included in BioVie's consensus?
The verified consensus includes 2 analysts.
How is BioVie's target upside or downside calculated?
The average target of $5.26 is divided by the recorded price of $1.17, then one is subtracted to produce +349.1%. This does not guarantee a future return.
When was BioVie's analyst forecast verified?
The data was verified on 2026-08-18. The dataset is valid through 2026-08-25.